Notice of Meeting, 47793 [2020-17224]
Download as PDF
<![CDATA[
47793
Federal Register / Vol. 85, No. 152 / Thursday, August 6, 2020 / Notices
Persons other than the registrants may
sell, distribute, or use existing stocks of
canceled products until supplies are
exhausted, provided that such sale,
distribution, or use is consistent with
the terms of the previously approved
labeling on, or that accompanied, the
canceled products.
Dated: July 28, 2020.
Mary Reaves,
Acting Director, Pesticide Re-Evaluation
Division, Office of Pesticide Programs.
[FR Doc. 2020–17114 Filed 8–5–20; 8:45 am]
BILLING CODE 6560–50–P
Receiver for each of the following
insured depository institutions, was
charged with the duty of winding up the
affairs of the former institutions and
liquidating all related assets. The
Receiver has fulfilled its obligations and
made all dividend distributions
required by law.
FEDERAL DEPOSIT INSURANCE
CORPORATION
Authority: 7 U.S.C. 136 et seq.
Notice of Termination of Receiverships
The Federal Deposit Insurance
Corporation (FDIC or Receiver), as
NOTICE OF TERMINATION OF RECEIVERSHIPS
Fund
Receivership name
City
10145 .................
10170 .................
United Security Bank ...........................................................
Town Community Bank & Trust ..........................................
Sparta ...................................................
Antioch .................................................
The Receiver has further irrevocably
authorized and appointed FDICCorporate as its attorney-in-fact to
execute and file any and all documents
that may be required to be executed by
the Receiver which FDIC-Corporate, in
its sole discretion, deems necessary,
including but not limited to releases,
discharges, satisfactions, endorsements,
assignments, and deeds. Effective on the
termination dates listed above, the
Receiverships have been terminated, the
Receiver has been discharged, and the
Receiverships have ceased to exist as
legal entities.
(Authority: 12 U.S.C. 1819)
Federal Deposit Insurance Corporation.
Dated at Washington, DC, on August 3,
2020.
James P. Sheesley,
Acting Assistant Executive Secretary.
[FR Doc. 2020–17208 Filed 8–5–20; 8:45 am]
BILLING CODE 6714–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Healthcare Research and
Quality
Notice of Meeting
Agency for Healthcare Research
and Quality, HHS.
AGENCY:
jbell on DSKJLSW7X2PROD with NOTICES
ACTION:
Notice.
The Agency for Healthcare
Research and Quality (AHRQ)
announces a Special Emphasis Panel
(SEP) meeting on ‘‘HEALTHCARE
INFORMATION TECHNOLOGY
RESEARCH (HITR) 2020/10–ZHS1
SUMMARY:
VerDate Sep<11>2014
17:13 Aug 05, 2020
Jkt 250001
HSR–F (01).’’ This SEP meeting will be
closed to the public.
DATES: August 26, 2020.
ADDRESSES: Agency for Healthcare
Research and Quality (Video Assisted
Review), 5600 Fishers Lane, Rockville,
Maryland 20850.
FOR FURTHER INFORMATION CONTACT:
Jenny Griffith, Committee Management
Officer, Office of Extramural Research,
Education and Priority Populations,
Agency for Healthcare Research and
Quality, (AHRQ), 5600 Fishers Lane,
Rockville, Maryland 20850, Telephone:
(301)427–1557.
SUPPLEMENTARY INFORMATION: A Special
Emphasis Panel is a group of experts in
fields related to health care research
who are invited by the AHRQ, and agree
to be available, to conduct on an as
needed basis, scientific reviews of
applications for AHRQ support.
Individual members of the Panel do not
attend regularly-scheduled meetings
and do not serve for fixed terms or a
long period of time. Rather, they are
asked to participate in particular review
meetings which require their type of
expertise.
The SEP meeting referenced above
will be closed to the public in
accordance with the provisions set forth
in 5 U.S.C. App. 2, section 10(d), 5
U.S.C. 552b(c)(4), and 5 U.S.C.
552b(c)(6). Grant applications for the
‘‘HEALTHCARE INFORMATION
TECHNOLOGY RESEARCH (HITR)
2020/10–ZHS1 HSR–F (01)’’ is to be
reviewed and discussed at this meeting.
The grant applications and the
discussions could disclose confidential
trade secrets or commercial property
such as patentable material, and
personal information concerning
PO 00000
Frm 00065
Fmt 4703
Sfmt 4703
State
Termination
date
GA
IL
8/1/2020
8/1/2020
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Agenda items for this meeting are
subject to change as priorities dictate.
Dated: August 3, 2020.
Virginia L. Mackay-Smith,
Associate Director.
[FR Doc. 2020–17224 Filed 8–5–20; 8:45 am]
BILLING CODE 4160–90–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2011–N–0424]
Agency Information Collection
Activities; Submission for Office of
Management and Budget Review;
Comment Request; Temporary
Marketing Permit Applications
Food and Drug Administration,
Health and Human Services (HHS).
ACTION: Notice.
AGENCY:
The Food and Drug
Administration (FDA) is announcing
that a proposed collection of
information has been submitted to the
Office of Management and Budget
(OMB) for review and clearance under
the Paperwork Reduction Act of 1995.
DATES: Submit written comments
(including recommendations) on the
collection of information by September
8, 2020.
ADDRESSES: To ensure that comments on
the information collection are received,
OMB recommends that written
comments be submitted to https://
SUMMARY:
E:\FR\FM\06AUN1.SGM
06AUN1
]]>Agencies
[Federal Register Volume 85, Number 152 (Thursday, August 6, 2020)]
[Notices]
[Page 47793]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-17224]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Agency for Healthcare Research and Quality
Notice of Meeting
AGENCY: Agency for Healthcare Research and Quality, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Agency for Healthcare Research and Quality (AHRQ)
announces a Special Emphasis Panel (SEP) meeting on ``HEALTHCARE
INFORMATION TECHNOLOGY RESEARCH (HITR) 2020/10-ZHS1 HSR-F (01).'' This
SEP meeting will be closed to the public.
DATES: August 26, 2020.
ADDRESSES: Agency for Healthcare Research and Quality (Video Assisted
Review), 5600 Fishers Lane, Rockville, Maryland 20850.
FOR FURTHER INFORMATION CONTACT: Jenny Griffith, Committee Management
Officer, Office of Extramural Research, Education and Priority
Populations, Agency for Healthcare Research and Quality, (AHRQ), 5600
Fishers Lane, Rockville, Maryland 20850, Telephone: (301)427-1557.
SUPPLEMENTARY INFORMATION: A Special Emphasis Panel is a group of
experts in fields related to health care research who are invited by
the AHRQ, and agree to be available, to conduct on an as needed basis,
scientific reviews of applications for AHRQ support. Individual members
of the Panel do not attend regularly-scheduled meetings and do not
serve for fixed terms or a long period of time. Rather, they are asked
to participate in particular review meetings which require their type
of expertise.
The SEP meeting referenced above will be closed to the public in
accordance with the provisions set forth in 5 U.S.C. App. 2, section
10(d), 5 U.S.C. 552b(c)(4), and 5 U.S.C. 552b(c)(6). Grant applications
for the ``HEALTHCARE INFORMATION TECHNOLOGY RESEARCH (HITR) 2020/10-
ZHS1 HSR-F (01)'' is to be reviewed and discussed at this meeting. The
grant applications and the discussions could disclose confidential
trade secrets or commercial property such as patentable material, and
personal information concerning individuals associated with the grant
applications, the disclosure of which would constitute a clearly
unwarranted invasion of personal privacy.
Agenda items for this meeting are subject to change as priorities
dictate.
Dated: August 3, 2020.
Virginia L. Mackay-Smith,
Associate Director.
[FR Doc. 2020-17224 Filed 8-5-20; 8:45 am]
BILLING CODE 4160-90-P
